Table 1.
Summary of the clinical characteristics of the patients with BCa, PCa and RCC.
| Characteristics | Variables | BCa (n = 29) |
PCa (n = 24) |
RCC (n = 12) |
|---|---|---|---|---|
| Age (years) | 67.92 ± 10.42 | 68.21 ± 5.54 | 62.17 ± 11.76 | |
| Sex (%) | Male | 29 (100) | 24 (100) | 12 (100) |
| SCr (mg/dL) | 0.98 ± 0.28 | 0.79 ± 0.13 | 0.98 ± 0.19 | |
| eGFR (mL/min/1.73 m2) | 81.81 ± 21.11 | 101.18 ±19.49 | 78.30 ±14.98 | |
| pT stage (%) | Ta | 13 (44.83) | - | - |
| Tis | 2 (6.89) | - | - | |
| T1 | 11 (37.93) | 3 (12.5) | 7 (58.33) | |
| T2 | 3 (15.15) | 6 (25.0) | - | |
| T3 | - | 14 (58.33) | 4 (33.33) | |
| T4 | - | 1 (4.17) | 1 (8.33) | |
|
WHO/ISUP
classification (%) |
Low | 15 (48.27) | - | - |
| High | 14 (51.72) | - | - | |
| GS (%) | 6 | - | 5 (20.83) | - |
| 7 | - | 3 (12.50) | - | |
| 8 | - | 8 (33.33) | - | |
| Above 8 | - | 8 (33.33) | - | |
| HSPC/CRPC (%) | - | 8 (33.3)/16 (66.7) | - | |
| Fuhrman grade (%) | G2 | - | - | 8 (66.67) |
| G3 | - | - | 2 (16.67) | |
| G4 | 2 (16.67) |
Abbreviations: SCr, Serum creatinine; eGFR, estimated glomerular filtration rate; pT, Pathologic Stage; GS, Gleason Score; HSPC, Hormone Sensitivity Prostate Cancer; CRPC, Castration Resistant Prostate Cancer. Note: Data are presented as mean ± standard deviation. eGFR was calculated using by MDRD formula.